Our scientists support advanced therapeutic modalities, including monoclonal and bispecific antibodies, cell and gene therapies, oligonucleotides, mRNA platforms, and small molecules.
In this video, learn how BA Sciences combines specialized scientific expertise, in-house assay development, validated analytical frameworks, and Quality by Design (QbD) principles to address modality-specific challenges while maintaining scientific rigor, quality, and regulatory compliance throughout drug development.
Contact us today to learn how we can support your next project.